ASAP News

An employee/applicant who has violated a DOT regulation is prohibited from returning to the performance of safety-sensitive functions for any DOT-covered employer until the individual successfully completes the return-to-duty process described in Part 40, Subpart O. The date of the violation has no […]

According to a recently released study, an annual increase in the number of trips to hospital emergency rooms as a result of alcohol has steadily risen, with an increase of 61 percent in the number of visits in 2014 as

The United States Coast Guard (USCG) announced that the minimum random drug testing rate for all covered employees will remain at 25% for the year 2018. Learn More

ASAP welcomed the 2018 New Year by heralding a new chapter in its continuing story as the nationwide leader in Substance Abuse Professional (SAP) services. On January 2, 2018, COO Laura Lacey Dashner, LCSW, became the new ASAP CEO! ASAP

Today, November 13, 2017, the Department of Transportation (DOT) published a final rule in the Federal Register (82 FR 52229).  The rule, among other items, added four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone).  It also added methylenedioxyamphetamine (MDA) as an

More than 63,600 people died from drug overdoses in 2016, a rate three times that of overdose deaths in 1999, according to the December 2017 report from the National Center for Health Statistics, which is part of the U.S. Centers

This action is based on a finding by the Administrator that the placement of these seven synthetic opioids in schedule I of the Controlled Substances Act (CSA) is necessary to avoid an imminent hazard to the public safety. When it

Finding new medications to effectively alleviate opioid withdrawal is an important step in enabling transition to medication protocols to treat opioid use disorders. Many patients drop out of treatment early if they cannot tolerate the withdrawal period and are then

Operators of gas, hazardous liquid, and carbon dioxide pipelines and operators of liquefied natural gas facilities must randomly select and test a percentage of all covered employees for prohibited drug use. Pursuant to 49 CFR 199.105(c)(1) the PHMSA minimum annual

To the medical director at Caron Treatment Centers, giving physicians and patients multiple options in treatment stands as a primary goal. That is why Joseph Garbely, DO, FASAM, is reassured by results of two recent studies, including one published this